NeuroSense Therapeutics Ltd. (NRSNW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
アナリスト予想 一株当たり利益（EPS） $-0.65 および 売上高 $0.00B 来期予想.
一株当たり利益（EPS）実績推移: 2024: 実績 $-0.55 vs 予想 $-0.65 (上回る +15.4%). アナリスト精度: 82%.
